Stock Analysis

Drozapol-Profil Third Quarter 2024 Earnings: zł0.14 loss per share (vs zł0.63 loss in 3Q 2023)

WSE:DPL
Source: Shutterstock

Drozapol-Profil (WSE:DPL) Third Quarter 2024 Results

Key Financial Results

  • Revenue: zł20.0m (up 39% from 3Q 2023).
  • Net loss: zł833.0k (loss narrowed by 78% from 3Q 2023).
  • zł0.14 loss per share (improved from zł0.63 loss in 3Q 2023).
earnings-and-revenue-history
WSE:DPL Earnings and Revenue History November 18th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Drozapol-Profil shares are up 1.4% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 2 warning signs for Drozapol-Profil you should know about.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.